|
⚲
|
| Keyboard |
| Bumpus Namandje
✚
|
|
|---|---|
| CIK # | 0002060594 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002060594] | |
| 4 | [0002060594] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bumpus Namandje | |
| Recursion Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-06-18 | Grant | 11,008 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2025-06-18 | Grant | 22,016 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-03-17 | Grant | 36,549 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2025-03-17 | Grant | 73,099 | $0.00 |